Clinical Trial Update: Trazodone Once a Day in Major Depression Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating once-daily trazodone for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Trazodone (trazodone)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED